期刊文献+

溶栓治疗时间对急性ST段抬高型心肌梗死病人住院期间MACE发生率的影响 被引量:2

Effect of the Delay of Thrombolytic Therapy and the Incidence of MACE in Inpatients with ST-segment Elevation Acute Myocardial Infarction
下载PDF
导出
摘要 目的探讨溶栓治疗时间的时机对急性ST段抬高型心肌梗死(STEMI)病人住院期间主要不良心脏事件(MACE)发生率的影响。方法选取2013年4月—2016年5月来驻马店市第一人民医院进行溶栓治疗的STEMI病人240例,按照是否溶通将病人分为溶通组(168例)和未溶通组(72例),各组再按照溶栓治疗时间不同分为0 h^5.9 h组、6 h^11.9 h组、≥12 h组,采用多因素Logistic回归模型分析不同溶栓时间对住院期间MACE发生率的影响。结果多因素Logistic回归结果显示,对相关因素进行调整后,无论是否溶通,相对于0 h^5.9 h组,随着溶栓时间的延迟,MACE发生风险均增加(P<0.05)。结论对STEMI病人采取溶栓治疗时,应尽可能在发病6 h内进行,随着溶栓时间的延迟,MACE的发生风险增加。 Objective To investigate the effect of the delay of thrombolytic therapy and the incidence of major adverse cardiac events (MACE) in inpatients with ST elevation acute myocardial infarction (STEMI).Methods A total of 240 patients underwent thrombo-lytic therapy with STEMI from April 2013 to May 2016 were categorized into recanalization group (n = 168) and non recanalization group (n = 72),were employed.The patients were stratified in 0 h to 5.9 h,6 h to 11.9 h and 〉 12 h respectively in each group ac-cording to the time receiving thrombolysis therapy.The Multifactor Logistic regression model was performed to investigate the relation-ship between the delay of thrombolytic therapy and the incidence of MACE in patients with STEMI.Results In recanalization group, the risks of MACE adjusted confounding factors in patients receiving thrombolytic therapy in 6 h to 11.9 h and more than 12 h were in-crease which compared with 0 h to 5.9 h group.The same effect was presented in non recanalization group.Conclusion Thrombolytic therapy should be carried out within 6 hours in patients with STEMI,MACE rates were significantly increased in patients with more than 12 hours’ treatment delay.
作者 郝翠平
出处 《中西医结合心脑血管病杂志》 2017年第13期4592-4595,共4页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词 急性ST段抬高型心肌梗死 溶栓 不良心脏事件 ST elevation acute myocardial infarction thrombolysis major adverse cardiac events
  • 相关文献

参考文献7

二级参考文献55

  • 1赵小祺,王春光,焦宏,要彤,薛乾隆.四逆汤对急性心肌梗死溶栓后再灌注损伤的保护作用[J].中国老年学杂志,2014,34(3):590-592. 被引量:13
  • 2陈跃峰,杨跃进.经皮冠状动脉介入治疗术后的无再流现象[J].心血管病学进展,2005,26(1):4-8. 被引量:48
  • 3急性心肌梗塞溶栓疗法参考方案(1996年7月修订)[J].中华心血管病杂志,1996,24(5):328-329. 被引量:1321
  • 4Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 5Lefkovitz J,Plow EF,Topol EJ.Platelet glycoprotein Ⅱb/Ⅲa receptor in cardiovascular medicine.N Engl J Med,1995,332:1553-1558.
  • 6Montalescot G,Barragan P,Wittenbery O,et al.For the ADMIRAL investigators.Platelet glycopretion Ⅱb/Ⅲa inhibition with coronary stenting for acute myocardial infarction.N Eng J Med,2001,21:1895-1903.
  • 7Lee DP,Herity NA,Hiatt BL,et al.Adjunctive platelet glycoprotein Ⅱb/Ⅲa inhibition with tirofiban before primary angioplasty improves angiographic outcome:Results of the Tirofiban give in the Emergency Room before primary angioplasty (TIGER-PA) pilot trial.Circulation,2003,107:1497-1501.
  • 8The TIMI study group.The thrombolysis in myocardial infarction (TIMI) trial;phase I findings.N Engl J Med,1985,312:932-936.
  • 9Henriques JP, Zijlstra F, Ottervanger JP, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J, 2002, 23:1112-1117.
  • 10Task Force on Myocardial Revascularization of the European Society of C, the European Association for Cardio-Thoracic S, European Association for Percutaneous Cardiovascular I, et al. Guidelines on myocardial revascularization. Eur Heart J, 2010, 31: 2501-2555.

共引文献2411

同被引文献20

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部